BACKGROUND & AIMS: Although the incidence of hepatocellular carcinoma (HCC) is
increasing in the United States, data from large prospective studies are limited. We evaluated the …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of
coronavirus disease 2019 (COVID-19), is associated with respiratory-related disease and …

Prior studies have suggested that natural killer (NK) cell function might be impaired in chronic
hepatitis C virus (HCV) infection. Circulating NK cell frequency and cytolytic activity were …

Coronavirus disease 2019 (COVID-19), the novel respiratory illness caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with severe morbidity and …

Retrospective studies suggest that subjects with chronic hepatitis C and advanced fibrosis
who achieve a sustained virological response (SVR) have a lower risk of hepatic …

Background & Aims: The most effective therapy currently available for treatment of chronic
hepatitis C virus (HCV) is the combination of peginterferon and ribavirin. This study evaluated …

Background In patients with chronic hepatitis C who do not have a response to antiviral
treatment, the disease may progress to cirrhosis, liver failure, hepatocellular carcinoma, and …

Abstract Knowledge of the presence of cirrhosis is important for the management of patients
with chronic hepatitis C (CHC). Most models for predicting cirrhosis were derived from small …

Silymarin, also known as milk thistle extract, inhibits hepatitis C virus (HCV) infection and
also displays antioxidant, anti-inflammatory, and immunomodulatory actions that contribute to …

Purpose: Preclinical data established IL15 as a homeostatic factor and powerful stimulator
of NK and CD8 + T-cell function, the basis for clinical testing. Experimental Design: A first-in-…